PSR-Agility Orphan Drug Development Wins ROAR Award for 'Best Orphan Drug CRO'
The PSR-Agility Orphan Drug Development partnership has been awarded 'Best Orphan Drug Contract Research Organisation' in the Rare & Orphan Advocacy and Research (ROAR) Awards.
The ROAR Awards were announced during the 4th Annual World Orphan Drug Congress Europe, 14–15 November 2013, in Geneva, Switzerland. The inaugural 2013 awards are an opportunity to recognise and honour achievements by organisations and individuals from industry, patient and rare disease advocacy communities.
“Winning this award as the PSR-Agility Orphan Drug Development partnership is an important acknowledgement for our pioneering work in the rare disease community during the last 5 years,” says Roger Legtenberg, CEO of PSR Orphan Experts. “As a unique specialised service provider, our way of integrating innovative regulatory and clinical approaches, and reaching crucial milestones for our clients has been the basis for winning this award. Our staff are all fully committed to the rare disease cause, taking part in fundraising events and other supportive activities.
“We established the PSR-Agility partnership so that our combined efforts in Europe and North America could make a difference for companies that are developing therapies for orphan products,” says Ellen Morgan, CEO of Agility. “Winning this award is a great confirmation that our efforts are working, and has made us even more motivated to continue our efforts.”
Orphan drugs present fundamentally different regulatory and operational challenges compared to their traditional counterparts. PSR-Agility Orphan Drug Development specialises in assisting companies to develop efficiencies and economies of scale to bring innovative new orphan products to market, thereby helping patients with rare diseases. Building successful partnerships with all stakeholders, including patient organisations, industry and key opinion leaders is of crucial importance. This is exemplified by the DevelopAKUre consortium, of which PSR Orphan Experts is one of the partners, winning a ROAR Award of the 'Best European Industry–Patient Organisation Engagement'.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance